Issue 2, 2012

Inhibition of bromodomain-mediated protein–protein interactions as a novel therapeutic strategy

Abstract

A multitude of epigenetic regulatory mechanisms is reflected in the dynamic nature of chromatin during different development stages as well as pathological states of human organisms. Apart from enzymatic processes, the recognition of histone modifications by reader protein modules contributes to the equilibrium between transcriptionally active and silent chromatin. Bromodomains are involved in the recognition of acetylated lysine containing substrates and in the downstream signalling of histoneacetylation. In part, this is mediated by the regulation of further acetylation reactions. Development of small molecules as epigenetic tools able to block proteinprotein interactions provided by bromodomains is a new emerging focus of epigenetic research, which also holds great potential for novel therapeutical approaches. This review is dealing with fundamentals of bromodomain structural biology, their inhibitors, and the relevance of these phenomena to molecular biology and drug discovery.

Graphical abstract: Inhibition of bromodomain-mediated protein –protein interactions as a novel therapeutic strategy

Article information

Article type
Review Article
Submitted
04 Aug 2011
Accepted
28 Sep 2011
First published
21 Oct 2011

Med. Chem. Commun., 2012,3, 123-134

Inhibition of bromodomain-mediated proteinprotein interactions as a novel therapeutic strategy

S. D. Furdas, L. Carlino, W. Sippl and M. Jung, Med. Chem. Commun., 2012, 3, 123 DOI: 10.1039/C1MD00201E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements